Publications

Recent Publications

242.          Assembly and Regulation of a Glycolytic Enzyme Complex on the Human Erythrocyte Membrane.  Campanella , M.E. , Chu , H. & P.S.       Low, Proc. Natl. Acad. Sci. 102, 2402-2407 (2005).

245.          The N-terminal 11 Amino Acids of Human Erythrocyte Band 3 are Critical for Aldolase Binding and Protein Phosphorylation:  Implications for Band 3 Function.  Perrotta, S., Borriello, A., Scaloni, A., De Franceschi, L.,  Brunati, A.M.,  Turrini, F., Nigro, V., del Giudice, E.M., Nobili, B., Conte, M.L., Rossi, F., Iolascon, A., Donella-Deana, A., Zappia, V., Poggi, V., Anong, W., Low, P.S., Narla, M. and Ragione, F.D., Blood 106, 4359-4366, (2005).

248.          Folate Receptor-targeted Immunotherapy:  Induction of Humoral and Cellular Immunity against Hapten-Decorated Cancer Cells. Lu, Y., Sega, E., and Low, P.S., Int. J. Cancer 116, 710-719 (2005).

249.          Increased Uptake of Folate Conjugates by Activated Macrophages in Experimental Hyperlipidemia.  Antohe F., Radulescu L., Puchianu E., Kennedy M.D., Low P.S., and Simionescu M., Cell Tissue Res. 320, 277-285 (2005).

250.          Folate Receptor-mediated Drug Targeting:  From Therapeutics to Diagnostics.  Hilgenbrink, A.R. and Low, P.S., J. Pharmaceutical Sciences 94, 2135-2146 (2005).

251.          In vitro and in vivo Two-Photon Luminescence Imaging of Single Gold Nanorods.  Wang, H., Huff, T.B., Zweifel, D.A., He, Wei, Low, P.S., Wei, A., and Cheng, J.X., Proc. Natl. Acad. Sci. U.S.A. 102, 15752-15756 (2005).

252.          Detection of Bacillus Subtilis Spores using Peptide-functionalized Cantilever Arrays.  Dhayal, B., Henne, W.A., Doorneweerd, D.D., Reifenberger, R.G. and Low, P.S., J. Am. Chem. Soc. 128, 3716-3721 (2006).

253.          Folate-targeted Immunotherapy Effectively Treats Established Adjuvant and Collagen-induced Arthritis.  Paulos, C.M., Varghese, B., Widmer, R., Breur, G.J., Vlashi, E. and Low, P.S., Arthritis Research and Therapy, 8:R77 (2006).  pdf                 .

254.          Detection of Folate Binding Protein with Enhanced Sensitivity using a Functionalized Quartz Crystal Microbalance Sensor.  Henne, W.A., Doorneweerd, D.D., Lee, J., Low, P.S., Savran, C., Anal. Chem. 78, 4880-4884 (2006).

255.          Mapping of Glycolytic Enzyme-binding Sites on Human Erythrocyte Band 3.  Chu , H., Low, P.S., Biochem. J. 400, 143-151 (2006).

256.          Evaluation of Disulfide Reduction during Receptor-mediated Endocytosis by using FRET Imaging.  Yang, J., Chen, H., Vlahov, I.R., Cheng, J.X. and Low, P.S., Proc. Natl. Acad. Sci. USA. 103, 13872-13877 (2006).

257.          T-cell Immunity to the Folate Receptor Alpha is Prevalent in Women with Breast or Ovarian Cancer.  Knutson, K.L., Krco, C.J., Erskine, C.L., Goodman, K., Kelemen, L.E., Wettstein, P.J., Low, P.S., Hartmann, L.C. and Kalli, K.R., J. Clin. Oncol. 24, 4254-4261 (2006).

258.          Synthesis and Activity of a Folate Peptide Camptothecin Prodrug.  Henne, W.A., Doorneweerd, D.D., Hilgenbrink, A.R., Kularatne, S.A. and Low, P.S., Bioorg. Med. Chem. Lett. 16, 5350-5355 (2006).

259.          Rate of Rupture and Reattachment of the Band 3-Ankyrin Bridge in the Human Erythrocyte Membrane.  Anong, W.A., Weis, T.L. and Low, P.S., J. Biol. Chem. 281, 22360-22366 (2006).

260.          In Vivo Quantitation of Rare Circulating Tumor Cells by Multiphoton Intravital Flow Cytometry.  He, W., Wang, H., Hartmann, L.C., Cheng, J.X. and Low, P.S., Proc. Natl. Acad. Sci. USA. 104, 11760-11765 (2007).

261.          Depletion of Folate-Receptor-Positive Macrophages Leads to Alleviation of Symptoms and Prolonged Survival in Two Murine Models of Systemic Lupus Erythematosus.  Varghese, B., Haase, N. and Low, P.S., Mol. Pharm. 4, 679-685. (2007).

262.          An 11-amino Acid Beta-hairpin Loop in the Cytoplasmic Domain of Band 3 is Responsible for Ankyrin Binding in Mouse Erythrocytes.  Stefanovic, M., Markham, N.O., Parry, E.M., Garrett-Beal, L.J., Cline, A.P., Gallagher, P.G., Low, P.S. and Bodine, D.M., Proc. Natl. Acad. Sci. U.S.A. 104, 13972-13977. (2007).

263.          Folate Receptor Overexpression is Associated with Poor Outcome in Breast Cancer.  Hartmann, L.C.,  Keeney, G.L., Lingle, W.L., Christianson, T.J.,  Varghese, B., Hillman, D., Oberg, A.L. and Low, P.S., Int. J. Cancer 121, 938-942, (2007).

264.          Characterization of the pH of Folate Receptor-containing Endosomes and the Rate of Hydrolysis of Internalized Acid-labile Folate-drug Conjugates.  Yang, J., Chen, H., Vlahov, I.R., Cheng, J.X. and Low, P.S., J. Pharmacol. Exp. Ther. 321, 462-468 (2007).

265.          Label-free Optical Detection of Anthrax-Causing Spores. Acharya, G., Doorneweerd, D.D.,  Chang, C.L., Henne, W.A., Low, P.S. and Savran , C.A. , J. Am. Chem. Soc. 129, 732-733 (2007).

266.          The Optimal Strategy for Drug Targeting.  Low, P.S., Mol. Pharm., 4, 629-630 (2007).

267.          Immunomagnetic Diffractometry for Detection of Diagnostic Serum Markers.  Acharya G, Chang CL, Doorneweerd DD, Vlashi E, Henne, WA, Hartmann LC, Low PS, Savran CA., J. Am. Chem. Soc. 129, 15824-15829 (2007).

268.          Discovery and Development of Folic-Acid-Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases.  Low, P.S., Henne, W.A. and Doorneweerd, D.D., Accounts of Chemical Research. 41, 120-129 (2008).

269.          Characterization of the Deoxyhemoglobin Binding Site on Human Erythrocyte Band 3:  Implications for O₂ Regulation of Erythrocyte Properties. Chu , H., Breite, A., Ciraolo, P., Franco, R.S. and Low, P.S.  Blood, 111, 932-8.  (2008).

            More Publications...